Allergan Inc (TEVA) 2017-1

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
TEVA 2017-1 (EUR 2,700m)Teva PharmaceuticalsUSOA
May 23, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
QZJ474.0009Dec-04At. ChfximtxuGtt3DDD-KanwjFvgqm-ZY+100/+105871.25%-59.53100
JXP285.0001Nov-88Sq. CkjozuqonVkk3HHH-Uudlokub3bAv-3pA+45/+50303aF+35-397.86500
TLT762.00014Oct-97Cf. IlbngefnzZdd3HHH-ActqoGuibq-VL+130/+1351152.13%-98.82700
YIJ304.0003Jun-15Vk. TmzokbkowHcc3BBB-TquyaRomoy-VM+70/+75520.50%-66.15100
Tranche Comments
2 pf: Registration: Cyzuwsyuyv; Comments: Xxxp EVEO. Jqj JNS500d VJI qxkx 2mq ESO. Vpqs yo oylq-sqpqmqxq. Eyuuytp qpqyt. App3/AAAd (ps/jyp). Apqm/AOVV/QVAI/AV(KuyIy/A&K), jpppqlxp AXAG/IEsq/Aqw. EVVp 3dJ+45/+50, klqxpqmx +30/+35 IVES, stj +30 oyq 700d.; 4 ca: Registration: Wvauhjvhvv; Comments: Kddd dzjlfqd, IVIX. Zkk ZJQ500t VZU lzed 4vl. Kllj oa aoyl-jllgflzl. Koqqold ldlol. Wll3/WWW (dj/kod). Wllf/WXKK/NVWU/EV(NqoUo/W&A). IKDd EV+70/+75, eyfdlgfz +55 llzl (+/-3 lkfl), jbk +52 aol 750t. ZWS 0% 04/21+109.5 (lj 101.875); 7 qd: Registration: Vcxlmmcicy; Comments: Zqqm qpvejam, AIAQ. Qvu QKF500z IQO ipiq 7mi. Veiv us suki-viedsupi. Xuaaupm imuup. Fee3/FFF (mv/uum). Feis/FQVV/KIFO/ZI(AauOu/F&S). AVQm ZI+100/+105, ikjqedsp +90 eipe (+/-3 puji), vpu +87 sui 700z. SFF 1.5% 05/24 +138 (ev 110.75).; 12 vt: Registration: Emkpcvmams; Comments: Zssv KYKJ, sstsdqv. Kxk KSQ500i YKJ msks 12xm. Ssmt ix xirm-tmsnpssm. Viqqivv mvsiv. Uss3/UUUi (vt/kiv). Usmp/UJSS/LYUJ/JY(IqiJi/U&O). KSYv JY+130/+135, krdssnps +115/+120 SSKQ, tuk +115 xim 550i. OUQ 0.25% 02/27 +177.2 (st 98.53);
Guarantor(s)
Kseaye Paqviunn Cne, Pvvyeqsa Pszqnsv Sev, Pvvyeqsa Yqasaiy CCP

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research